Related Experiment Video

Updated: May 4, 2026

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on: April 15, 2017

20.3K

The use of antiviral drugs for influenza: Guidance for practitioners, 2012/2013; Paediatric summary

Upton D Allen,

    Paediatrics & Child Health
    |January 15, 2014
    PubMed

    Insights

    This practice point provides guidance on using antiviral drugs for managing influenza in children and youth. It focuses on Canadian recommendations for antiviral therapy and addresses secondary bacterial infections in severe cases.

    Area of Science:

    • Pediatric Infectious Diseases
    • Clinical Pharmacology

    Background:

    • Influenza remains a significant public health concern in pediatric populations.
    • Management of pediatric influenza requires up-to-date clinical guidelines.
    • Secondary bacterial infections complicate severe influenza cases.

    Purpose of the Study:

    • To summarize antiviral drug use for influenza management in children and youth for the 2012/2013 season.
    • To provide clinicians with an update on Canadian recommendations for pediatric antiviral therapy.
    • To highlight the role of secondary bacterial infections in severe influenza.

    Main Methods:

    • Excerpting recommendations from a full-length Canadian clinical update.
    • Focusing on antiviral drug use for prevention and treatment in pediatric patients.
    • Reviewing information on chemoprophylaxis and secondary bacterial pathogens.

    Main Results:

    • Summarizes current practices for antiviral drug use in pediatric influenza.
    • Provides specific recommendations for clinicians treating children and youth.
    • Emphasizes the importance of considering secondary bacterial infections.

    Conclusions:

    • Antiviral drug management is crucial for pediatric influenza.
    • Clinicians should adhere to updated Canadian recommendations for effective therapy.
    • Vigilance for secondary bacterial infections is essential in severe pediatric influenza cases.

    Keywords:
    Antiviral therapyChildrenInfluenzaNeuraminidase inhibitors

    More Related Videos

    Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses09:07

    Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses

    Published on: January 20, 2017

    9.8K
    A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection05:21

    A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

    Published on: August 14, 2019

    28.9K

    Related Concept Videos

    Influenza01:27

    Influenza

    Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
    87
    Inhibitors of Viral Protein Synthesis01:30

    Inhibitors of Viral Protein Synthesis

    Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
    58
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    408
    Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

    Pharmacokinetics: Drug–Food and Drug–Viral Interactions

    A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
    695
    Drugs Used in Upper Respiratory Disorders: Overview01:16

    Drugs Used in Upper Respiratory Disorders: Overview

    Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
    Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
    1.0K
    Drugs Used in Lower Respiratory Disorders: Overview01:17

    Drugs Used in Lower Respiratory Disorders: Overview

    Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
    Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
    1.6K